Samar Masoumi-Moghaddam

623 total citations
21 papers, 487 citations indexed

About

Samar Masoumi-Moghaddam is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Samar Masoumi-Moghaddam has authored 21 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Surgery. Recurrent topics in Samar Masoumi-Moghaddam's work include Pineapple and bromelain studies (8 papers), Fibroblast Growth Factor Research (6 papers) and Kruppel-like factors research (5 papers). Samar Masoumi-Moghaddam is often cited by papers focused on Pineapple and bromelain studies (8 papers), Fibroblast Growth Factor Research (6 papers) and Kruppel-like factors research (5 papers). Samar Masoumi-Moghaddam collaborates with scholars based in Australia and United States. Samar Masoumi-Moghaddam's co-authors include David L. Morris, Afshin Amini, Anahid Ehteda, Ai‐Qun Wei, Gregory Robertson, Winston Liauw, Afshin Amini, Kunle Odunsi, Malaka Ameratunga and Nicholas C. Wong and has published in prestigious journals such as Cancer Research, Oncogene and Annals of Oncology.

In The Last Decade

Samar Masoumi-Moghaddam

21 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samar Masoumi-Moghaddam Australia 13 316 100 94 73 68 21 487
Xiangliang Zhang China 15 412 1.3× 121 1.2× 88 0.9× 345 4.7× 50 0.7× 25 668
Parul Gupta India 11 260 0.8× 42 0.4× 185 2.0× 65 0.9× 20 0.3× 41 582
Jennifer Mahoney United States 7 276 0.9× 25 0.3× 256 2.7× 87 1.2× 75 1.1× 10 550
Seraina Faes Switzerland 12 370 1.2× 67 0.7× 156 1.7× 149 2.0× 7 0.1× 23 628
P. Godwin Ireland 4 173 0.5× 39 0.4× 88 0.9× 97 1.3× 7 0.1× 6 330
J. Rebecca Liu United States 14 321 1.0× 26 0.3× 149 1.6× 132 1.8× 85 1.3× 18 555
M Katano Japan 11 245 0.8× 113 1.1× 169 1.8× 139 1.9× 19 0.3× 19 539
Qingxiang Gao China 13 254 0.8× 67 0.7× 84 0.9× 124 1.7× 8 0.1× 43 503
Kaushlendra Tripathi United States 17 521 1.6× 23 0.2× 223 2.4× 118 1.6× 22 0.3× 31 718
Yijun Cao China 10 218 0.7× 42 0.4× 103 1.1× 136 1.9× 4 0.1× 14 399

Countries citing papers authored by Samar Masoumi-Moghaddam

Since Specialization
Citations

This map shows the geographic impact of Samar Masoumi-Moghaddam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar Masoumi-Moghaddam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar Masoumi-Moghaddam more than expected).

Fields of papers citing papers by Samar Masoumi-Moghaddam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samar Masoumi-Moghaddam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar Masoumi-Moghaddam. The network helps show where Samar Masoumi-Moghaddam may publish in the future.

Co-authorship network of co-authors of Samar Masoumi-Moghaddam

This figure shows the co-authorship network connecting the top 25 collaborators of Samar Masoumi-Moghaddam. A scholar is included among the top collaborators of Samar Masoumi-Moghaddam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samar Masoumi-Moghaddam. Samar Masoumi-Moghaddam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Youfang, Samar Masoumi-Moghaddam, Clare G. Fedele, et al.. (2023). UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma. Oncogene. 42(17). 1360–1373. 9 indexed citations
2.
Starbuck, Kristen, et al.. (2017). Abstract 956: Novel oral small molecule CXCR4 inhibitor improves activity of immune checkpoint blockade in ovarian cancer mouse model. Cancer Research. 77(13_Supplement). 956–956. 3 indexed citations
3.
Starbuck, Kristen, et al.. (2017). Abstract 947: CXCR4 in combination with immune check point inhibition in ovarian cancer mouse model demonstrates potential for novel therapeutic strategies. Cancer Research. 77(13_Supplement). 947–947. 2 indexed citations
4.
Masoumi-Moghaddam, Samar, Ali Amini, & David L. Morris. (2016). Is mucin a determinant of peritoneal dissemination of gastrointestinal cancer? Analysis of mucin depletion in two preclinical models. Clinical & Translational Oncology. 19(2). 261–264. 1 indexed citations
5.
Amini, Afshin, Samar Masoumi-Moghaddam, Anahid Ehteda, Winston Liauw, & David L. Morris. (2016). Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells.. PubMed. 6(2). 350–69. 32 indexed citations
6.
Amini, Afshin, Samar Masoumi-Moghaddam, & David L. Morris. (2016). Utility of Bromelain and N-Acetylcysteine in Treatment of Peritoneal Dissemination of Gastrointestinal Mucin-Producing Malignancies. PubMed. 36(6). 3224–5. 35 indexed citations
7.
Masoumi-Moghaddam, Samar, et al.. (2015). Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells: significance of combination therapy. Annals of Oncology. 26. ii25–ii25. 3 indexed citations
8.
Masoumi-Moghaddam, Samar, Afshin Amini, Ai‐Qun Wei, Gregory Robertson, & David L. Morris. (2015). Intratumoral interleukin-6 predicts ascites formation in patients with epithelial ovarian cancer: A potential tool for close monitoring. Journal of Ovarian Research. 8(1). 58–58. 13 indexed citations
9.
Masoumi-Moghaddam, Samar, Afshin Amini, Ai‐Qun Wei, Gregory Robertson, & David L. Morris. (2015). Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer. International Journal of Cancer. 137(3). 560–570. 25 indexed citations
10.
Masoumi-Moghaddam, Samar, et al.. (2015). Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer. Annals of Oncology. 26. ii21–ii21. 23 indexed citations
11.
Amini, Afshin, Samar Masoumi-Moghaddam, Anahid Ehteda, et al.. (2015). Abstract LB-007: Synergistic inhibition of human gastric and colorectal cancers by Bromelain and N-acetylcysteine: An in vivo study. Cancer Research. 75(15_Supplement). LB–7. 1 indexed citations
12.
Amini, Afshin, Samar Masoumi-Moghaddam, & David L. Morris. (2015). In vivo assessment of growth-inhibitory and mucin-depleting effects of bromelain and N-acetylcysteine in peritoneal carcinomatosis models. Annals of Oncology. 26. ii28–ii28. 2 indexed citations
13.
Masoumi-Moghaddam, Samar, Afshin Amini, Ai‐Qun Wei, Gregory Robertson, & David L. Morris. (2015). Sprouty 1 predicts prognosis in human epithelial ovarian cancer.. PubMed. 5(4). 1531–41. 19 indexed citations
14.
Masoumi-Moghaddam, Samar, Afshin Amini, Ai‐Qun Wei, Gregory Robertson, & David L. Morris. (2015). Sprouty2 protein in prediction of post-treatment ascites in epithelial ovarian cancer treated with adjuvant carbotaxol chemotherapy.. PubMed. 5(8). 2498–507. 4 indexed citations
15.
Amini, Afshin, Samar Masoumi-Moghaddam, Anahid Ehteda, Winston Liauw, & David L. Morris. (2015). Depletion of mucin in mucin-producing human gastrointestinal carcinoma: Results fromin vitroandin vivostudies with bromelain and N-acetylcysteine. Oncotarget. 6(32). 33329–33344. 29 indexed citations
16.
Amini, Afshin, Samar Masoumi-Moghaddam, Anahid Ehteda, & David L. Morris. (2014). Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy. Journal of Experimental & Clinical Cancer Research. 33(1). 92–92. 58 indexed citations
17.
Masoumi-Moghaddam, Samar, et al.. (2014). Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects. Orphanet Journal of Rare Diseases. 9(1). 71–71. 44 indexed citations
18.
Masoumi-Moghaddam, Samar, Afshin Amini, & David L. Morris. (2014). The developing story of Sprouty and cancer. Cancer and Metastasis Reviews. 33(2-3). 695–720. 120 indexed citations
19.
Masoumi-Moghaddam, Samar, Afshin Amini, Anahid Ehteda, Ai‐Qun Wei, & David L. Morris. (2014). The expression of the Sprouty 1 protein inversely correlates with growth, proliferation, migration and invasion of ovarian cancer cells. Journal of Ovarian Research. 7(1). 61–61. 17 indexed citations
20.
Amini, Afshin, Samar Masoumi-Moghaddam, Anahid Ehteda, & David L. Morris. (2014). Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro : significance of combination therapy. Journal of Experimental & Clinical Cancer Research. 33(1). 92–92. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026